Ammonium perfluorooctanoate substantially alters phenotype and cytokine secretion of human monocyte-derived dendritic cells in vitro

Ahuja, V; Eisenblätter, M; Ignatius, R; Stahlmann, R

HERO ID

1937253

Reference Type

Journal Article

Year

2009

Language

English

PMID

19874235

HERO ID 1937253
In Press No
Year 2009
Title Ammonium perfluorooctanoate substantially alters phenotype and cytokine secretion of human monocyte-derived dendritic cells in vitro
Authors Ahuja, V; Eisenblätter, M; Ignatius, R; Stahlmann, R
Journal Immunopharmacology and Immunotoxicology
Volume 31
Issue 4
Page Numbers 641-646
Abstract Perfluoroalkyl carboxylic acids (PFCA) are commercially used for their surfactant properties combined with chemical and thermal stability. Differentiation of peripheral monocytes to immature dendritic cells (DCs) in the presence of the PFCA, ammonium perfluorooctanoate (APFO, 200 microM) led to a considerably increased expression of CD86 and HLA-DR on immature DCs. However, these phenotypic changes were not reflected by an increased T cell-stimulatory capacity of the cells. Notably, activated, fully mature APFO-treated DCs secreted significantly less IL-12 and IL-10 than control cells. Thus, APFO at non-cytotoxic concentration affects the phenotype and cytokine secretion of human DCs.
Doi 10.3109/08923970902947317
Pmid 19874235
Wosid WOS:000275067400020
Is Certified Translation No
Dupe Override No
Is Public Yes
Language Text English